Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News PerkinElmer reveals new immunoassay partnership

PerkinElmer reveals new immunoassay partnership

12th May 2009

PerkinElmer has announced a new partnership it hopes will lead to the development of new assay and sample technology.

The group has entered a deal with San Diego-based BioLegend, a firm that specialises in immunological reagents in the field of international biomedical research.

Brad Kraft, president of BioLegend, said the agreement would help both companies move towards providing better biology and pathobiology solutions for use in the research of disease.

He added that there were certain restrictions on current systems that the firms would work together to overcome.

"The future of high throughput assays lies in an increased need for automation," Mr Kraft explained. "Many current immunological assay platforms have major drawbacks when it comes to meeting requirements for automation."

BioLegend will now utilise its new partner’s AlphaLISA assay system to offer its own brand of immunoassay testing solutions.

Also this week, PerkinElmer announced it would appear at Deutsche Bank’s 34th Annual Healthcare Conference on Monday May 18th.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.